Elawoman, a New Delhi-based fertility services aggregator, has raised $3 million in a series A round funding from Chiratae Ventures and Alkemi Venture Partners.
The announcement has come weeks after IDG Ventures India and Alkemi Venture Partners had invested in Elawoman.
IDG Ventures India renamed itself as Chiratae on Tuesday.
The fund will be used to enhance technology platform and expand in non-metro cities in India and in Asia-Pacific countries, said Elawoman, operated by Treemark Solutions Pvt Ltd.
The Asia-Pacific region alone has more than 70 million couples going through the challenges of infertility. This number is only expected to increase given the impact of stress and other lifestyle issues are having on conception, said Ranjith Menon, utive director at Chiratae Ventures.
Founded in 2016, Elawoman uses artificial intelligence-driven doctor-patient matching algorithm, which maps the patient requirements to the doctor specialization and suggests the best doctor to the patient based on past medical history, budget and treatment needs.
It also provides a patient management system to the doctors and fertility centres for the management of patients and maintaining their treatment and billing history.
Until now, Elawoman has about 5,400 fertility doctors and clinics listed on its platform.
Founded by Alka Goel, the investment firm was earlier a partner at consulting firm McKinsey and co., and Preet Pal, who was a principal at healthcare-focused private equity fund Asian Healthcare Fund.